Bandingkan Harga & Kinerja Harum Energy Tbk. (HRUM) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Harum Energy Tbk. dan Organon Pharma Indonesia Tbk.: Harum Energy Tbk. diperdagangkan di Rp920 (kapitalisasi pasar 12,5 T, volume 24 jam 12,79 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Harum Energy Tbk. jauh lebih besar — sekitar 119,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HRUM | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 12,5 T | 104,4 M |
Volume | 12,79 jt | — |
Lot | 127,94 rb | — |
Perputaran | 11,74 M | — |
Harga Rata-rata | 917,66 | — |
Nilai Transaksi | 11,74 M | — |
Harga Ekuilibrium Indikatif | 920 | — |
Volume Ekuilibrium Indikatif | 2,52 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Harum Energy Tbk.
PT Harum Energy (the company) was established under its original name of PT Asia Antrasit on Oct 12th, 1995 then changed to PT Harum Energy based on Notaries Deed dated Nov 13, 2007 and the deed of establishment was approved by the the Ministry of Justice dated Feb 13, 2008. The Company’s articles of association has been amended several times, most recently by notarial deed No. 11 of Sugito Tedjamulja, S.H., dated Mar 3, 2010, concerning among others, the change in the Company’s name and for the amendments in the company's whole articles of Association to comply with the requirements of the Capital Market and Financial Institutions Supervisory Agency.
Selengkapnya di halaman HRUM →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
